Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
3/4/2015
1
AMD Masqueraders
J. Michael Jumper, MDWest Coast RetinaSan Francisco, CA
No DisclosuresOff label use of bevacizumabwill be discussed
Presentation Va 20/60
3/4/2015
2
47 y.o WF
7 Months Later, Va 20/30
D DystrophyDDegeneration
I InfectiousInflammatoryImmunologicIatrogenicIdiopathic
DITHCO
T TumorTraumaToxicity
H HereditaryHematologic
C Congenital
O Other
3/4/2015
3
What is AMD?
A chronic and progressive retinal disease of adults > 50 y.o. which begins with deposits of lipid protein andwith deposits of lipid, protein and inflammation in the macula. These deposits (drusen) can lead to swelling, bleeding and scarring of the retina, any of which can cause central vision loss.
Geographic Atrophy Choroidal Neovascularization
Drusen and Drusen-like Deposits
• Small/hard drusen
• Large/soft drusen
• Cuticular drusen (basal laminar deposits)laminar deposits)
• Subretinal drusenoid debris (reticular pseudodrusen)
• < 63 μm
• Common in > 40 y.o.
• Not diagnostic for AMD
3/4/2015
4
Drusen and Drusen-like Deposits
• Small/hard drusen
• Large/soft drusen
• Cuticular drusen (basal laminar deposits)laminar deposits)
• Subretinal drusenoid debris (reticular pseudodrusen)
• ≥ 125 μm
• Associated with basal linear deposits
• Associated with advanced AMD
Spaide RF, Curcio CA. Retina (2010) 30(9); 1441-54.
RPE
Drusen and Drusen-like Deposits
• Large/soft drusen
• Small/hard drusen
• Cuticular drusen (basal laminar deposits)laminar deposits)
• Subretinal drusenoid debris (reticular pseudodrusen)
• Once believed distinct from AMD, now thought to be part of AMD spectrum
• Small, yellow• FA: starry skySpaide RF, Curcio CA. Retina (2010) 30(9); 1441-54.
Drusen and Drusen-like Deposits
• Large/soft drusen
• Small/hard drusen
• Cuticular drusen (basal laminar deposits)laminar deposits)
• Subretinal drusenoid debris (reticular pseudodrusen)
• More apparent with fundus autofluoresence
• Complications:– Vitelliform macular lesion– CNV – 21%– Geographic atrophy - 11%Spaide RF, Curcio CA. Retina (2010) 30(9); 1441-54.
3/4/2015
5
Drusen and Drusen-like Deposits
• Large/soft drusen
• Small/hard drusen
• Cuticular drusen (basal laminar deposits)laminar deposits)
• Subretinal drusenoid debris (reticular pseudodrusen)
• Deposits under the retina
• Similar biochemically to the sub-RPE deposits
• FA: subtle changesSpaide RF, Curcio CA. Retina (2010) 30(9); 1441-54.
Drusen and Drusen-like Deposits
• Large/soft drusen
• Small/hard drusen
• Cuticular drusen (basal laminar deposits)laminar deposits)
• Subretinal drusenoid debris (reticular pseudodrusen)
• FAF: Hypoautofluorescentspots corresponding to deposits
• OCT: conical deposits above the RPE in the subretinal space
Spaide RF, Curcio CA. Retina (2010) 30(9); 1441-54.
Adult Onset Foveal Pigment Epithelial Dystrophy (AOFPED)
3/4/2015
6
Acquired Vitelliform Lesions• Definition: “Presence of a
well-circumscribed area of yellowish subretinal material detected in patients older than 40 years”*
• TerminologyAdult onset foveal macular
1987
– Adult-onset foveal macular dystrophy
– Adult-onset foveal pigment epithelial dystrophy
– Pattern dystrophy of the RPE
– Adult vitelliform dystrophy
– Adult Best disease
*Freund KB, et al. Retina (2011) 31:13-25.
20/50
20/80
2000
• Composition– Degenerated photoreceptor
outer segments– Between the outer retina
and RPE• Genetic causes
– Best 1– PRPH2/RDS
Acquired Vitelliform Lesions
– PRPH2/RDS• Other causes
– Cuticular drusen– Reticular pseudodrusen– Traction maculopathies– CSR– AMD– Isolated
Acquired Vitelliform Lesions
• Angiography– Early blockage, late
staining
– Hypofluoresence from the lipofuscin
• Autofluorescence– Intense
hyperautofluorescence
– Helps differentiate from CNV
– Suggests Lipofuscin
FA Late
FAF
3/4/2015
7
62 yo WM, dark spot, RE
Drusen
62 yo WM, dark spot, RE
• Intravitreal injection of bevacizumab given
• Follow up 10 days later: no change in vision, OCTvision, OCT
• Observed
• Eventually required reduced fluence PDT rapid resolution
Consider a diagnostic challenge with an Anti-VEGF agent in the rare cases when you are not sure if CNV is present
3/4/2015
8
Ways that CSR Can Masquerade as AMD
• Acquired vitelliform lesion
• Diffuse ooze pattern of FA leakage
• Fibrin can mimic fibrosis• Fibrin can mimic fibrosis
• Chronic CSR– RPE atrophy
– Cytoid macular degeneration
Ways that CSR Can Masquerade as AMD
• Acquired vitelliform lesion
• Diffuse ooze pattern of FA leakage
• Fibrin can mimic fibrosis• Fibrin can mimic fibrosis
• Chronic CSR– RPE atrophy
– Cytoid macular degeneration
Ways that CSR Can Masquerade as AMD
• Acquired vitelliform lesion
• Diffuse ooze pattern of FA leakage
• Fibrin can mimic fibrosis• Fibrin can mimic fibrosis
• Chronic CSR– RPE atrophy
– Cytoid macular degeneration
3/4/2015
9
Ways that CSR Can Masquerade as AMD
• Acquired vitelliform lesion
• Diffuse ooze pattern of FA leakage
• Fibrin can mimic fibrosis• Fibrin can mimic fibrosis
• Chronic CSR– RPE atrophy
– Cytoid macular degeneration
From Iida T, et al. Retina (2003) 23:1-7.
Ways To Differentiate CSR From AMD
• FA findings– Pinpoint leak
• Multifocal in 29%• Patterns
– Inkblot– Smokestack (7-20%)Smokestack (7 20%)
– RPE guttering
• OCT findings– Roughening
protrusions– CSR has a thickened
choroid whereas AMD has choroidal thinning
Ways To Differentiate CSR From AMD
• FA findings– Pinpoint leak
• Multifocal in 29%• Patterns
– Inkblot– Smokestack (7-20%)Smokestack (7 20%)
– RPE guttering
• OCT findings– Roughening
protrusions– CSR has a thickened
choroid whereas AMD has choroidal thinning
Imamura Y, et al. , Ophthalmology 2011;118:700–705.
FAF
Guttering pattern on FA is strongly suggestive of CSR
3/4/2015
10
Ways To Differentiate CSR From AMD
• FA findings– Pinpoint leak
• Multifocal in 29%• Patterns
– Inkblot– Smokestack (7-20%)Smokestack (7 20%)
– RPE guttering
• OCT findings– Roughening
protrusions– CSR has a thickened
choroid whereas AMD has choroidal thinning
Ways To Differentiate CSR From AMD
• FA findings– Pinpoint leak
• Multifocal in 29%• Patterns
– Inkblot– Smokestack (7-20%)Smokestack (7 20%)
– RPE guttering
• OCT findings– Roughening
protrusions– CSR has a thickened
choroid whereas AMD has choroidal thinning
Imamura Y, et al. , Retina (2009) 29: 1469-1473
Normal
CSR
Polypoidal ChoroidalVasculpathy AMD
Chung SE, Kang SW, Lee JH, Kim YT. Ophthalmology 2011;118:840–845
3/4/2015
11
Polypoidal Choroidal Vasculopathy
• Serosanguineousmaculopathy with…– Clinically visible orange-red
subretinal nodules– Spontaneous massive
subretinal hemorrhage– Notched or hemorrhagic
PED– Lack of response to VEGF
therapy• Of presumed AMD cases
– Caucasians 4-10%– Asians 24-55%
PCV• Suspected to be a primary
abnormality of the choroid• Indocyaine Green
Angiography (ICGA)– Less affected by blood– Identify polyps– Direct PDT– PDT + Ranibizumab was
better than Ranibizumabmonotherapy*
*Koh a, et al. Retina (2012) 32: 1453‐64.
3/4/2015
12
Polypoidal Choroidal Vasculpathy
47 y.o Healthy WF With Fluctuating Vision OS x 1 Year
Presentation 7 Months Later
D DystrophyDDegeneration
I InfectiousInflammatoryImmunologicIatrogenicIdiopathic
DITHCO
T TumorTraumaToxicity
H HereditaryHematologic
C Congenital
O Other
3/4/2015
13
D DystrophyDDegeneration
I InfectiousInflammatoryImmunologicIatrogenicIdiopathic
DITHCO
T TumorTraumaToxicity
H HereditaryHematologic
C Congenital
O Other
Presentation 7 Months Later
47 y.o Healthy WF With Fluctuating Vision OS x 1 Year
Presentation 7 Months Later
11 Months Later B-Cell Lymphoma
Conclusions• Phenotype of AMD is variable
- Drusen
- Atrophy
- Pigment alteration
- CNV
• Not all drusen are alike: small drusen are not diagnostic of AMD
• Acquired vitelliform lesions can be differentiated from CNV most easily by the FAF pattern- CNV dark
- AVL bright
• Choroidal thickening with EDI-OCT can differentiate CSR and PCV from AMD
3/4/2015
14
Conclusions• Consider an anti-VEGF injection challenge in cases
that may represent wet AMD- Atypical CSR
- Acquired vitelliform lesions with subretinal fluid
• Consider ICGA to rule out polypoidal choroidalvasculopathy in patients who are poorly responsive to y yanti-VEGF therapy- Especially in non-Caucasion patients
- PCV is more common than originally suspected, even in Caucasians
• When all else fails….DITHCO
Cone Dystrophy AOFPEDPolypoidal Choroidal
Vasculopathy
Chronic CSR Myopic DegenerationVitreoretinalLymphoma
Stargardt DzType 2 membranoproliferative
glomerulonephritis
North Carolina Macular Dystophy
AMD Masqueraders
J. Michael Jumper, MDWest Coast RetinaSan Francisco, CA